{"id":958408,"date":"2026-05-05T16:43:00","date_gmt":"2026-05-05T20:43:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/innovage-announces-financial-results-for-the-fiscal-third-quarter-ended-march-31-2026\/"},"modified":"2026-05-05T16:43:00","modified_gmt":"2026-05-05T20:43:00","slug":"innovage-announces-financial-results-for-the-fiscal-third-quarter-ended-march-31-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/innovage-announces-financial-results-for-the-fiscal-third-quarter-ended-march-31-2026\/","title":{"rendered":"InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026"},"content":{"rendered":"
\n

DENVER, May 05, 2026 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (\u201cInnovAge\u201d or the \u201cCompany\u201d) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal third quarter ended March 31, 2026.<\/p>\n

We delivered a solid third quarter, reflecting continued improvement in operating execution and financial performance,\u201d said Patrick Blair, Chief Executive Officer of InnovAge. \u201cThese results are being driven by stronger performance across our centers and the benefits of the investments we\u2019ve made over the past several years to strengthen our platform. At the same time, we continue reinvesting in our clinical teams, technology, and quality capabilities to further improve participant outcomes and experience over the long term. Based on our performance year to date, we are raising our fiscal 2026 revenue and Adjusted EBITDA guidance.<\/p>\n

\n
\n Financial Results<\/u>
\n <\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\n\u00a0<\/td>\n\n Three Months Ended March 31,<\/strong>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n 2026<\/strong>\n <\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n 2025<\/strong>\n <\/td>\n\u00a0<\/td>\n<\/tr>\n
\n in thousands, except percentages and per share amounts<\/em>\n <\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Total revenues<\/td>\n\u00a0<\/td>\n$<\/td>\n251,943<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n218,142<\/td>\n\u00a0<\/td>\n<\/tr>\n
Loss Before Income Taxes<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(29,773<\/td>\n)<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(11,061<\/td>\n)<\/td>\n<\/tr>\n
Net Loss<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(29,940<\/td>\n)<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(11,133<\/td>\n)<\/td>\n<\/tr>\n
Net Loss margin<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(11.9<\/td>\n)%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(5.1<\/td>\n)%<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Net Loss Attributable to InnovAge Holding Corp.<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(29,461<\/td>\n)<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n(11,378<\/td>\n)<\/td>\n<\/tr>\n
Net Loss per share – basic and diluted<\/td>\n\u00a0<\/td>\n$<\/td>\n(0.22<\/td>\n)<\/td>\n\u00a0<\/td>\n$<\/td>\n(0.08<\/td>\n)<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Center-level Contribution Margin(1)<\/sup><\/td>\n\u00a0<\/td>\n$<\/td>\n61,020<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n40,747<\/td>\n\u00a0<\/td>\n<\/tr>\n
Adjusted EBITDA(1)<\/sup><\/td>\n\u00a0<\/td>\n$<\/td>\n30,495<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n10,792<\/td>\n\u00a0<\/td>\n<\/tr>\n
Adjusted EBITDA margin(1)<\/sup><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n12.1<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n4.9<\/td>\n%<\/td>\n<\/tr>\n<\/table>\n

\n
\n
\n
Fiscal Third Quarter 2026 Financial Performance<\/u>
\n <\/strong>\n <\/p>\n